Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial

Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Schrijvers, 2004, From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines, Endocr Rev, 25, 971, 10.1210/er.2003-0018 Khosla, 2006, Microalbuminuria, Clin Lab Med, 26, 635, 10.1016/j.cll.2006.06.005 He, 2007, Clinical research of Yiqi Sanju Formula in treating central obese men at high risk of metabolic syndrome, J Chin Integr Med, 5, 263, 10.3736/jcim20070307 Lou, 2008, Effects of Yiqi Sanju Formula on nonalcoholic fatty liver disease: a randomized controlled trial, J Chin Integr Med, 6, 793, 10.3736/jcim20080805 Wang, 2011, Inspection of the relationship between disease and syndrome complex: analogous syndrome complex in the same disease, Zhongguo Zhong Xi Yi Jie He Za Zhi, 31, 1023 Xue, 2011, Effects of “Yiqi Zengmin Recipe” on microalbuminuria and insulin resistance of type 2 diabetic in rats, Zhongguo Lao Nian Xue Za Zhi, 4213 Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults, 2007, Chinese guidelines on prevention and treatment of dyslipidemia in adults, Zhonghua Xin Xue Guan Bing Za Zhi, 35, 390 Esteghamati, 2010, Metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes, Acta Diabetol, 47, 125, 10.1007/s00592-009-0131-6 Klausen, 2005, New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death, Hypertension, 46, 33, 10.1161/01.HYP.0000169153.78459.50 Abdul-Ghani, 2006, Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome, Isr Med Assoc J, 8, 378 Parvanova, 2006, Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion, Diabetes, 55, 1456, 10.2337/db05-1484 Chan, 1996, Albuminuria, insulin resistance and dyslipidaemia in Chinese patients with non-insulin-dependent diabetes (NIDDM), Diabet Med, 13, 150, 10.1002/(SICI)1096-9136(199602)13:2<150::AID-DIA33>3.0.CO;2-J Mykkänen, 1998, Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study, Diabetes, 47, 793, 10.2337/diabetes.47.5.793 Kurella, 2005, Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults, J Am Soc Nephrol, 16, 2134, 10.1681/ASN.2005010106 Adler, 2003, Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64), Kidney Int, 63, 225, 10.1046/j.1523-1755.2003.00712.x Lane, 2004, Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective, Am J Physiol, 286, F442 Hillege, 2002, Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population, Circulation, 106, 1777, 10.1161/01.CIR.0000031732.78052.81 Wahba, 2007, Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease, Clin J Am Soc Nephrol, 2, 550, 10.2215/CJN.04071206 Hernandez, 2011, Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials, Am J Cardiovasc Drugs, 11, 115, 10.2165/11587580-000000000-00000 Wang, 2007, Foundation and application of aggregation syndrome theory in traditional Chinese medicine, J Chin Integr Med, 5, 111, 10.3736/jcim20070201 Wang, 2008, Pay more attention to “analogous syndrome complex in the same disease and treating the same disease with analogous methods”, J Chin Integr Med, 6, 441, 10.3736/jcim20080501 Wang, 2004, Effect of Astragalus polysaccharides and berberine on carbohydrate metabolism and cell differentiation in 3T3 L1 adipocytes, Zhongguo Zhong Xi Yi Jie He Za Zhi, 24, 926 Liu, 2008, Effects of berberine on cell proliferation, peroxisome proliferation activated receptor gamma, CAAT/enhancer binding protein mRNA and protein expression in 3T3-L1 pre-adipocytes, Zhongguo Zhong Xi Yi Jie He Za Zhi, 28, 1005 He, 2008, Effects of Pollen Typhae total flavones on mRNA expressions of peroxisome proliferator-activated receptors in 3T3-L1 adipocytes, J Chin Integr Med, 6, 939, 10.3736/jcim20080912 Feng, 2012, Palmitate contributes to insulin resistance through downregulation of the Src-mediated phosphorylation of Akt in C2C12 myotubes, Biosci Biotechnol Biochem, 76, 1356, 10.1271/bbb.120107 Feng, 2012, Pollen Typhae total flavone improves insulin-induced glucose uptake through the beta-arrestin-2-mediated signaling in C2C12 myotubes, Int J Mol Med, 30, 914, 10.3892/ijmm.2012.1061 Zhang, 2011, Yi-Qi-Zeng-Min-Tang, a Chinese medicine, ameliorates insulin resistance in type 2 diabetic rats, World J Gastroenterol, 17, 987